We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Healthcare | 14.47% |
| 3 | Technology | 14.27% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Semtech
SMTC
$14B
| $271K | ﹤0.01% |
11,351
+782
| +7% | +$17.8K |
|
|
GNCMA
1702
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $271K | ﹤0.01% |
17,135
+176
| +1% | +$2.87K |
|
1703
Scansource
SCSC
$1.18B
| $270K | ﹤0.01% |
7,280
+73
| +1% | +$2.87K |
|
1704
Evercore
EVR
$10.4B
| $269K | ﹤0.01% |
6,093
-402
| -6% | -$20K |
|
1705
Kemper
KMPR
$1.65B
| $269K | ﹤0.01% |
8,668
-190
| -2% | -$5.92K |
|
1706
Grupo Aval
AVAL
$6.39B
| $268K | ﹤0.01% |
+33,241
| New | +$259K |
|
1707
RBC Bearings
RBC
$15.3B
| $268K | ﹤0.01% |
3,694
+123
| +3% | +$9.02K |
|
1708
Weibo
WB
$1.62B
| $268K | ﹤0.01% |
+9,421
| New | +$229K |
|
1709
Matsons
MATX
$7.15B
| $267K | ﹤0.01% |
8,281
-1,432
| -15% | -$49.5K |
|
|
IPHS
1710
DELISTED
Innophos Holdings, Inc.
IPHS
| $267K | ﹤0.01% |
+6,315
| New | +$237K |
|
|
MESG
1711
DELISTED
XURA INC COM (DE)
MESG
| $267K | ﹤0.01% |
10,949
-450
| -4% | -$10.2K |
|
|
BEL
1712
DELISTED
Belmond Ltd.
BEL
| $266K | ﹤0.01% |
26,919
+2,284
| +9% | +$21.4K |
|
|
INN
1713
Summit Hotel Properties
INN
$615M
| $265K | ﹤0.01% |
20,016
+457
| +2% | +$5.46K |
|
1714
Rogers Corp
ROG
$2.35B
| $265K | ﹤0.01% |
4,344
-106
| -2% | -$6.53K |
|
|
CFNL
1715
DELISTED
Cardinal Financial Corp
CFNL
| $265K | ﹤0.01% |
+12,079
| New | +$260K |
|
1716
Materion
MTRN
$4.95B
| $264K | ﹤0.01% |
+10,682
| New | +$274K |
|
1717
Douglas Dynamics
PLOW
$909M
| $264K | ﹤0.01% |
10,266
-1,374
| -12% | -$30.9K |
|
1718
Pebblebrook Hotel Trust
PEB
$2.04B
| $263K | ﹤0.01% |
10,011
-2,953
| -23% | -$78.3K |
|
1719
Stock Yards Bancorp
SYBT
$2.52B
| $263K | ﹤0.01% |
9,330
-836
| -8% | -$22.7K |
|
1720
Cohen & Steers
CNS
$3.74B
| $262K | ﹤0.01% |
6,474
-1,072
| -14% | -$42.1K |
|
1721
3D Systems Corp
DDD
$523M
| $260K | ﹤0.01% |
18,966
-365
| -2% | -$5.28K |
|
|
ODP
1722
DELISTED
ODP
ODP
| $260K | ﹤0.01% |
7,843
-1,043
| -12% | -$50.9K |
|
|
MDC
1723
DELISTED
M.D.C. Holdings, Inc.
MDC
| $260K | ﹤0.01% |
14,809
+2,750
| +23% | +$47.5K |
|
|
LMNX
1724
DELISTED
Luminex Corp
LMNX
| $260K | ﹤0.01% |
12,844
-204
| -2% | -$4.09K |
|
1725
Ares Capital
ARCC
$13.9B
| $259K | ﹤0.01% |
18,211
-833
| -4% | -$12.4K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.